Candelabra aloe (Aloe arborescens) in the therapy and prophylaxis of upper respiratory tract infections: traditional use and recent research results.
Aloe arborescens (Candelabra Aloe) has been used in the treatment of upper respiratory tract infections in Central and Eastern European countries for many decades. Originally introduced to support the healing and recovery in cornea transplant patients, aqueous A. arborescens extracts soon became popular in the treatment of upper respiratory tract infections with a focus on toddlers and children. Recent preclinical and clinical data show that immunomodulatory, antiinflammatory, and antiviral effects contribute to its therapeutic efficacy. Based on its well documented, longstanding traditional use and its excellent safety and tolerability, A. arborescens may be considered a valuable addition to the spectrum of herbal medicinal products for the treatment and prophylaxis of upper respiratory tract infections, in particular common cold, in adults and children.
PhytoLab GmbH & Co. KG, Vestenbergsgreuth, Germany.
Petra
P
Bastian
Andrzej M
AM
Fal
Jerzy
J
Jambor
Anna
A
Michalak
Britta
B
Noster
Hartwig
H
Sievers
Anke
A
Steuber
Natalia
N
Walas-Marcinek
D000293:Adolescent; D000504:Aloe; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008519:Medicine, Traditional; D009894:Opportunistic Infections / Q000188:drug therapy / Q000517:prevention & control; D008517:Phytotherapy / Q000379:methods*; D010936:Plant Extracts / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000517:prevention & control; D055502:Secondary Prevention
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000998:Antiviral Agents; D007155:Immunologic Factors; D010936:Plant Extracts